Kyowa Kirin signs exclusive Latin America distribution deal with Knight Therapeutics for Poteligeo

Kyowa Kirin signed an exclusive distribution agreement with Knight Therapeutics for Poteligeo (mogamulizumab) in Latin America, with approvals to be sought before commercialisation in Argentina, Brazil, Colombia and Mexico.